Related Experiment Video

Updated: Jul 4, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

The risk of hepatocellular carcinoma in patients with previous malignancy

Abby B Siegel1, Russell B McBride, Hashem B El-Serag

  • 1Department of Medicine, College of Physicians and Surgeons, Columbia University, New York, New York 10033, USA. aas54@columbia.edu

Cancer Investigation
|June 24, 2008
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Related Experiment Videos

Last Updated: Jul 4, 2026

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma
12:24

A Three-Dimensional Spheroid Model to Investigate the Tumor-Stromal Interaction in Hepatocellular Carcinoma

Published on: September 30, 2021

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice
10:35

Generation of Subcutaneous and Intrahepatic Human Hepatocellular Carcinoma Xenografts in Immunodeficient Mice

Published on: September 25, 2013

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
06:38

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...

Articles linked to this work by shared authors, journal, and citation graph.

Pembrolizumab Monotherapy in Sorafenib-Treated and Treatment-Naïve Advanced Hepatocellular Carcinoma: Long-Term Follow-up of the Open-Label, Phase II KEYNOTE-224 Study.

Clinical cancer research : an official journal of the American Association for Cancer Research·2026

Impact of Hepatitis B Virus Infection on the Efficacy and Safety of Pembrolizumab plus Chemotherapy for Advanced Biliary Tract Cancer in the KEYNOTE-966 Study.

Cancer research communications·2026

Effect of pembrolizumab on viral hepatitis load and transaminases in advanced hepatocellular carcinoma.

Annals of hepatology·2025

Second-line pembrolizumab for advanced HCC: Meta-analysis of the phase III KEYNOTE-240 and KEYNOTE-394 studies.

JHEP reports : innovation in hepatology·2025

Transarterial chemoembolisation combined with lenvatinib plus pembrolizumab versus dual placebo for unresectable, non-metastatic hepatocellular carcinoma (LEAP-012): a multicentre, randomised, double-blind, phase 3 study.

Lancet (London, England)·2025

Lenvatinib plus pembrolizumab versus lenvatinib plus placebo for advanced hepatocellular carcinoma (LEAP-002): a randomised, double-blind, phase 3 trial.

The Lancet. Oncology·2023

Variations of Blood Concentration Levels of Reactive Carbonyl Species Among Three Case-Control Studies of Breast and Colorectal Cancer.

Cancer investigation·2026

Psychosocial and Sociodemographic Factors Associated with Perceived Barriers to Physical Activity in Patients Receiving Chemotherapy.

Cancer investigation·2026

Clinical, Allied Health, and Research/Advocacy Professionals' Perspectives on Body Image and Support Needs for Young Adults with Cancer; A Qualitative Study.

Cancer investigation·2026

Mechanisms of Resistance to Immune Checkpoint Inhibitors and Therapeutic Strategies to Overcome Them: An Integrative Review.

Cancer investigation·2026

Predictive Value of the High-Sensitivity C-Reactive Protein/HDL-Cholesterol Ratio for Cardiovascular and Cancer-Specific Mortality in Cancer Survivors: A Study from NHANES 2015-2018.

Cancer investigation·2026

Precision Pancreatic Cancer Care: From Early Detection to Adaptive Precision Oncology.

Cancer investigation·2026

Malignant Arrhythmias Caused by Pericardial Lipomas: Benign, Yet Deadly.

JACC. Case reports·2026

Prognostic factors and survival in HHV8 positive diffuse large B cell lymphoma: a national cancer database analysis.

Leukemia & lymphoma·2026

Daratumumab in Combination With High-Dose Cytarabine and Amsacrine as an Effective Salvage Therapy and Bridge to Allogeneic Hematopoietic Stem Cell Transplantation for Refractory T-Cell Acute Lymphoblastic Leukemia: A Case Report.

Pediatric blood & cancer·2026

Transverse Myelitis and Guillain-Barré Syndrome in Pediatric Lymphoid Malignancies: An International Retrospective Study.

Pediatric blood & cancer·2026

Complement Activation by Post-Translationally Modified Proteins: Links to Chronic Inflammation and Autoimmunity.

Immunological reviews·2026

Pericardial Decompression Syndrome after Drainage of Malignant Pericardial Effusion: A Case Report.

Journal of investigative medicine high impact case reports·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us